BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16038060)

  • 1. The costs of institutional review boards.
    Bhat S; Hegde TT
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16038060
    [No Abstract]   [Full Text] [Related]  

  • 2. The costs of institutional review boards.
    Dickler HB; Korn D
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16034023
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost of institutional review boards in academic medical centers.
    Sugarman J; Getz K; Speckman JL; Byrne MM; Gerson J; Emanuel EJ;
    N Engl J Med; 2005 Apr; 352(17):1825-7. PubMed ID: 15858200
    [No Abstract]   [Full Text] [Related]  

  • 4. Determining the costs of Institutional Review Boards.
    Speckman JL; Byrne MM; Gerson J; Getz K; Wangsmo G; Muse CT; Sugarman J;
    IRB; 2007; 29(2):7-13. PubMed ID: 17847609
    [No Abstract]   [Full Text] [Related]  

  • 5. Central institutional review board-facilitated review metrics omit critical components.
    Katz MS; Smith ML
    J Clin Oncol; 2010 Feb; 28(6):e105; author reply e106. PubMed ID: 20100953
    [No Abstract]   [Full Text] [Related]  

  • 6. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rules of the game: institutional review boards.
    Lubowitz JH; Poehling GG; Burkhart SS
    Arthroscopy; 2008 Apr; 24(4):373-4. PubMed ID: 18375265
    [No Abstract]   [Full Text] [Related]  

  • 8. The controversy surrounding central institutional review boards.
    Savage TA; Mukherjee D
    PM R; 2010 Jan; 2(1):57-61; discussion 62-3. PubMed ID: 20129514
    [No Abstract]   [Full Text] [Related]  

  • 9. Institutional review boards: the cost to academic medical centers.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):287. PubMed ID: 16265262
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for clinical research in developing countries.
    Vray M; Simon F; Bompart F;
    Therapie; 2007; 62(3):217-27. PubMed ID: 17803889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 12. Institutional review boards (IRBs) would have an increased role in international research.
    Maloney DM
    Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
    [No Abstract]   [Full Text] [Related]  

  • 13. Industry-sponsored research in developing countries.
    Abbas EE
    Contemp Clin Trials; 2007 Nov; 28(6):677-83. PubMed ID: 17434813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of recent regulatory notifications on an institutional ethics committee.
    Bhide SS; Jalgaonkar SV; Katkar JV; Shetty YC; Tripathi RK; Marathe PA; Thatte UM
    Indian J Med Ethics; 2016; 1(4):210-214. PubMed ID: 27473067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplant research with pediatric donors: when can institutional review boards approve it?
    Peerzada JM; Wendler D
    Transplantation; 2006 Jun; 81(12):1616-20. PubMed ID: 16794524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost of institutional review board procedures in multicenter observational research.
    Humphreys K; Trafton J; Wagner TH
    Ann Intern Med; 2003 Jul; 139(1):77. PubMed ID: 12834327
    [No Abstract]   [Full Text] [Related]  

  • 19. Variability in the costs of institutional review board oversight.
    Byrne MM; Speckman J; Getz K; Sugarman J
    Acad Med; 2006 Aug; 81(8):708-12. PubMed ID: 16868423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How ethical are for-profit institutional review boards?
    Lancet; 2009 Apr; 373(9673):1400. PubMed ID: 19394516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.